Long term protection after hepatitis B vaccination.
A survey of persistence of anti-HBs after hepatitis B vaccination has shown that five years after vaccination on a sample of 152 persons, or 82.53%, stands at >10 IU/I. Long term immunogenicity of vaccinated children remained at 88.89%, health workers 79.41% and drug addicts 64.28%. The results of these studies in Bosnia and Herzegovina show the high level of protection hepatitis B vaccine against HBV infection. Vaccination against viral hepatitis B results in immunologic memory response among the vaccinated, and even after a decrease of anti-HB level following the third vaccine dose inoculation, a booster dose is not needed. Immunity remains steady and a booster dose is not recommended.
Puvacić
Sandra
S
Institute of Epidemiology, Faculty of Medicine, University of Sarajevo, Cekalusa 90, 71000 Sarajevo, Bosnia and Herzegovina.
Ravlija
Jelena
J
Puvacić
Zlatko
Z
Curić
Ivan
I
D000328:Adult; D017522:Bosnia and Herzegovina; D002648:Child; D006282:Health Personnel; D006510:Hepatitis B Antibodies / Q000097:blood*; D017325:Hepatitis B Vaccines / Q000276:immunology*; D006801:Humans; D007117:Immunization, Secondary; D007156:Immunologic Memory; D020380:Needs Assessment; D019966:Substance-Related Disorders / Q000097:blood; D013997:Time Factors
D006510:Hepatitis B Antibodies; D017325:Hepatitis B Vaccines